• All sections
  • A - Human necessities
  • A61K - Preparations for medical, dental or toiletry purposes
  • A61K 47/68 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment

Patent holdings for IPC class A61K 47/68

Total number of patents in this class: 12279

10-year publication summary

234
473
831
1002
962
1136
1187
1317
1507
1165
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
SeaGen Inc
590
257
Daiichi Sankyo Company, Limited
1886
208
Regeneron Pharmaceuticals, Inc.
4312
203
Genentech, Inc.
3988
193
MedImmune Limited
617
151
Hanmi Pharm. Co., Ltd.
574
148
Dyne Therapeutics, Inc.
247
135
ImmunoGen, Inc.
399
134
The Regents of the University of California
20035
113
Bristol-myers Squibb Company
4867
94
Novartis AG
10726
91
Bolt Biotherapeutics, Inc.
119
89
Pfizer Inc.
3364
78
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
294
77
ADC Therapeutics SA
122
65
Zymeworks Inc.
261
65
Hoffmann-La Roche Inc.
3456
63
CytomX Therapeutics, Inc.
223
60
Memorial Sloan-Kettering Cancer Center
1940
60
Yale University
2400
60
Other owners 9935